Inventor · disambiguated record
William H. Frey, Ii
Also filed as: FREY II WILLIAM H · FREY II WILLIAM HOWARD · FREY WILLIAM H · FREY WILLIAM H II
57 granted patents·20 pending applications·995 citations·filing 1994–2023
99Inventor score
Files withCHIRON CORP12HEALTHPARTNERS RES FOUNDATION11FREY II WILLIAM H10HEALTHPARTNERS RES & EDUCATION8YEOMANS DAVID C8
Top patents by PatentIndex Score
77 records- 0197US6313093B1Method for administering insulin to the brainCHIRON CORP·Filed 1999·Granted Nov 6, 2001·160 cites·30 claims
- 0296US9249424B2Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseasesUNIV MINNESOTA·Filed 2013·Granted Feb 2, 2016·79 cites·16 claims
- 0396US6991785B2Method for administering a cytokine to the central nervous system and the lymphatic systemCHIRON CORP·Filed 2002·Granted Jan 31, 2006·87 cites·48 claims
- 0496US6180603B1Method for administering neurologic agents to the brainCHIRON CORP·Filed 1997·Granted Jan 30, 2001·131 cites·41 claims
- 0595US8252745B2Methods for treatment of headaches by administration of oxytocinYEOMANS DAVID C·Filed 2011·Granted Aug 28, 2012·32 cites·15 claims
- 0695US8202838B2Methods for treatment of headaches by administration of oxytocinYEOMANS DAVID C·Filed 2009·Granted Jun 19, 2012·27 cites·15 claims
- 0795US5624898AMethod for administering neurologic agents to the brainRAMSEY FOUNDATION·Filed 1994·Granted Apr 29, 1997·134 cites·10 claims
- 0893US8198240B2Methods for treatment of headaches by administration of oxytocinYEOMANS DAVID C·Filed 2008·Granted Jun 12, 2012·21 cites·17 claims
- 0993US7618615B2Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemiaHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Nov 17, 2009·27 cites·13 claims
- 1092US8501691B2Methods for treatment of headaches by administration of oxytocinYEOMANS DAVID C·Filed 2012·Granted Aug 6, 2013·13 cites·16 claims
- 1192US8258096B2Therapy procedure for drug delivery for trigeminal painYEOMANS DAVID C·Filed 2011·Granted Sep 4, 2012·15 cites·19 claims
- 1292US7786166B2Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agentHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Aug 31, 2010·16 cites·32 claims
- 1391US10987423B2Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulinHEALTHPARTNERS RES & EDUCATION·Filed 2020·Granted Apr 27, 2021·2 cites·10 claims
- 1491US8283160B2Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous systemFREY II WILLIAM H·Filed 2008·Granted Oct 9, 2012·14 cites·23 claims
- 1589US7776312B2Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2006·Granted Aug 17, 2010·9 cites·10 claims
- 1689US7084126B1Methods and compositions for enhancing cellular function through protection of tissue componentsHEALTHPARTNERS RES FOUNDATION·Filed 2001·Granted Aug 1, 2006·26 cites·5 claims
- 1788US8609088B2Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseasesWOLF DANIEL A·Filed 2012·Granted Dec 17, 2013·13 cites·17 claims
- 1887US12503501B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 23, 2025·0 cites·13 claims
- 1987US10967061B2Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulinHEALTHPARTNERS RES & EDUCATION·Filed 2019·Granted Apr 6, 2021·2 cites·14 claims
- 2086US9205066B2Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 8, 2015·2 cites·11 claims
- 2186US8153604B2CNS-tumor treatment method and compositionDEEN DENNIS F·Filed 2007·Granted Apr 10, 2012·15 cites·8 claims
- 2286US6342478B1Method for administering fibroblast growth factor to the brainCHIRON CORP·Filed 1999·Granted Jan 29, 2002·51 cites·34 claims
- 2385US7273618B2Method for administering agents to the central nervous systemCHIRON CORP·Filed 2002·Granted Sep 25, 2007·21 cites·7 claims
- 2484US11559579B2Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulinHEALTHPARTNERS RES & EDUCATION·Filed 2020·Granted Jan 24, 2023·1 cites·10 claims
- 2583US8622993B2Device and method for delivering therapeutic substances to the maxillary sinus of a patientFREY II WILLIAM H·Filed 2010·Granted Jan 7, 2014·21 cites·9 claims
- 2683US7972595B2Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analogHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Jul 5, 2011·4 cites·9 claims
- 2783US6407061B1Method for administering insulin-like growth factor to the brainCHIRON CORP·Filed 1999·Granted Jun 18, 2002·47 cites·34 claims
- 2882US9556260B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GBAXALTA INC·Filed 2014·Granted Jan 31, 2017·4 cites·31 claims
- 2982US9211273B2Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 15, 2015·1 cites·14 claims
- 3082US9211272B2Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 15, 2015·1 cites·16 claims
- 3181US10314911B2Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulinHEALTHPARTNERS RES & EDUCATION·Filed 2015·Granted Jun 11, 2019·3 cites·8 claims
- 3281US8568691B2Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoningFREY II WILLIAM H·Filed 2009·Granted Oct 29, 2013·2 cites·4 claims
- 3380US7989502B2Intranasal delivery of modafinilSTANFORD RES INST INT·Filed 2009·Granted Aug 2, 2011·6 cites·21 claims
- 3479US9216161B2Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 22, 2015·1 cites·16 claims
- 3578US10279012B2Methods of treating and preventing social communication disorder in patients by intranasal administration of insulinHEALTHPARTNERS RES & EDUCATION·Filed 2014·Granted May 7, 2019·1 cites·11 claims
- 3676US9445991B2Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous systemFREY II WILLIAM H·Filed 2016·Granted Sep 20, 2016·1 cites·20 claims
- 3775US8772263B2Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ionsFREY II WILLIAM H·Filed 2005·Granted Jul 8, 2014·1 cites·9 claims
- 3875US2022211875A1Intranasal administration of adeno-associated virus to treat central nervous system disordersUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 3974US11851481B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin gTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Dec 26, 2023·0 cites·15 claims
- 4074US10144776B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GBAXALTA INC·Filed 2016·Granted Dec 4, 2018·1 cites·27 claims
- 4172US9707193B2Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS INST·Filed 2013·Granted Jul 18, 2017·0 cites·40 claims
- 4271US9801835B2Method of pre-treating patients for stroke comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUND·Filed 2013·Granted Oct 31, 2017·0 cites·18 claims
- 4371US9636312B2Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUND·Filed 2013·Granted May 2, 2017·0 cites·23 claims
- 4471US9629819B2Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUND·Filed 2013·Granted Apr 25, 2017·0 cites·18 claims
- 4569US9345676B2Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted May 24, 2016·0 cites·27 claims
- 4669US8592485B2Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disordersBRESIN HANSON LEAH RANAE·Filed 2011·Granted Nov 26, 2013·2 cites·10 claims
- 4767US9636313B2Method of treating spinal cord injury comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUND·Filed 2013·Granted May 2, 2017·0 cites·19 claims
- 4863US2018289839A1Intranasal therapeutic delivery of adeno-associated virus to central nervous systemUNIV MINNESOTA·Filed 2016·Application pending·0 cites
- 4962US9480649B2Lipid microparticle growth factor formulationsHANSOM LEAH R·Filed 2007·Granted Nov 1, 2016·1 cites·66 claims
- 5062US2019055307A1Treatment of central nervous system disorders by intranasal administration of immunoglobulin gBAXALTA INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →